Abstract
Most RNA viruses exists as a heterogeneous mixture of closely related viral genome in the host, which is the result of high error rates in RNA replication and selected by various viral and host factors. The spectrum of this spectrum of related genomes within a host is referred as quasispecies (1). This important biological characteristics of RNA virus is believed to contribute to viral persistence in the presence of host immune system and during treatment with antiviral agents. Hepatitis C virus (HCV), being a single-strand RNA virus, is no exception. In HCV genome, the most heterogeneous regions he within the envelope 2 region, which are referred to as hypervariable regions (HVRs). The HVRs in HCV are believed to be the result of high nucleotide variation and immune selection pressure (2). Because of its heterogeneity, this is a good region for the study of HCV quasispecies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Steinhauer, D. A and Holland, J J (1987) Rapid evolution of RNA viruses Annu Rev Microbiol 41, 409ā433
Weiner, A J., Geysen, H M, Christopherson, C, Hall, J E., Mason, T. J., Saracco, G., et al (1992) Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants, potential role in chronic HCV infections Proc Natl Acad. Sci. USA 89, 3468ā3472
Hoofnagle, J H, Mullen, K D., Jones, D B., Rustig, V, Di Bisceghe, A, Peters, M., et al. (1986) Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon A preliminary report. N. Engl J Med 315, 1575ā1578
Davis, G L, Balart, L. A, Schiff, E R., Lindsay, K., Bodenheimer, H C., Perrillo, R. P., et al (1989) Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl. J Med 321, 1501ā1506.
Hagiwara, H., Hayashi, N, Mita, E., Takehara, T, Kasahara, A., Fusamoto, H., et al (1993) Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy Gastroenterology 104, 877ā883.
Tsubota, A., Chayama, K., Ikeda, K, Yasuji, A., Koida, I, Saitoh, S, et al (1994) Factors predictive of response to inetrferon-a therapy in hepatitis C virus infection. Hepatology 19, 1088ā1094
Kanazawa, Y, Hayashi, N, Mita, E, Li, T., Hagiwara, H, Kasahara, A, et al. (1997) Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients Hepatology 20, 1121ā1130
Mizakami, M., Lau, J. Y N, Suzuki, K., Nakano, T, and Gojobori, T (1994) Differential sensitivity of hepatitis C virus quasispecies to interferon-Ī± therapy J Hepatol 21, 884ā886
Mizokami, M., Gojobori, T, and Lau, J Y. N (1994) Molecular evolutionary virology its application to hepatitis C virus. Gastroenterology 107, 1181,1182.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 1998 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Mizokami, M., Ohno, T. (1998). Determination of HCV Quasispecies by Cloning and Sequencing. In: Lau, J.YN. (eds) Hepatitis C Protocols. Methods in Molecular Medicineā¢, vol 19. Humana Press. https://doi.org/10.1385/0-89603-521-2:207
Download citation
DOI: https://doi.org/10.1385/0-89603-521-2:207
Publisher Name: Humana Press
Print ISBN: 978-0-89603-521-8
Online ISBN: 978-1-59259-260-9
eBook Packages: Springer Protocols